(Q44131272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

2

Carla Ghelardini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

4

Carla Uslenghi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Irene Grazioli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

published in

Pharmacological Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

245-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

The impact of migraine: Epidemiology, risk factors, and co-morbidities

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

The antimigraine drug ergotamine is endowed with antihyperalgesic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Caffeine induces central cholinergic analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Treatment of psychosis with prochlorperazine in the ICU setting.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Central mechanism of indomethacin analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

A review of the pharmacokinetic and pharmacodynamic factors in the potentiation of the antinociceptive effect of nonsteroidal anti-inflammatory drugs by caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

The analgesic effects of caffeine in headache.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-6618%2802%2900126-3

7 January 2021

10.1016/S1043-6618(02)00126-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220967%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference